In this article we summarize the experimental studies providing novel concepts for cell-enhancement strategies to aid the treatment of peripheral artery occlusive and ischemic heart disease.
Incidence of Ischemic Heart Disease According to Diagnostic Manifestation — Forty-four Months' Experience. Hypertensive disease, uncomplicated, was diagnosed when only a casual sphygmomanometric ...
Ischemic heart disease is the most common cause of death ... Depending on the symptoms and risk, treatment may be with medication, percutaneous coronary intervention (angioplasty) or coronary ...
for the treatment of ischemic heart failure of reduced ejection fraction (HFrEF). “This most recent meeting with PMDA had several important outcomes,” said Peter Altman, Ph.D., BioCardia’s President ...